<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01159652</url>
  </required_header>
  <id_info>
    <org_study_id>63-SR-10</org_study_id>
    <nct_id>NCT01159652</nct_id>
  </id_info>
  <brief_title>Hypnotic Medications and Memory: Effect of Drug Exposure During the Night</brief_title>
  <official_title>Hypnotic Medications and Sleep-dependent Memory Consolidation: the Effect of Variable Drug Exposure During the Night</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's Hospital, Chesterfield, Missouri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Academy of Sleep Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Luke's Hospital, Chesterfield, Missouri</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of two hypnotic medications, zolpidem
      extended release and zaleplon, on memory. It is expected that a hypnotic with shorter drug
      duration will allow greater memory consolidation than a hypnotic with longer drug duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A growing body of evidence has demonstrated that sleep promotes memory consolidation in
      healthy individuals. However, little research has been conducted regarding the effect of
      hypnotics on sleep-dependent memory. One study found that zopiclone (7.5 mg), but not
      brotizolam (0.25 mg), impaired sleep-dependent memory consolidation in normal sleepers.
      Another study reported significant impairment of sleep-dependent memory on a motor task with
      triazolam (0.375 mg), but not with zolpidem immediate release (10 mg). These studies provide
      some evidence that sedative-hypnotic drugs may impair sleep-dependent memory consolidation,
      but further investigation is clearly needed in this area. Because hypnotics are commonly
      prescribed for insomnia, it is important to determine if there is a significant risk of
      impairment in sleep-dependent memory consolidation associated with these medications.
      Further, investigation of alternative doses and drug regimens upon memory consolidation
      appears warranted.

      The purpose of the current study is to determine the effect of two hypnotic medications on
      sleep-dependent memory consolidation in normal sleepers. Zolpidem extended release, which
      will be active for most of the sleep period when administered at bedtime, will be compared to
      zaleplon, which will be active for half of the sleep period when administered in the middle
      of the night. This comparison allows us to address the question of whether a few hours of
      drug-free sleep results in better memory consolidation than sleep with drug throughout the
      night.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Memory</measure>
    <time_frame>8 timepoints: 4 evenings and 4 mornings</time_frame>
    <description>Two memory tasks will be used to assess memory.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Sleep</condition>
  <condition>Memory</condition>
  <arm_group>
    <arm_group_label>Bedtime Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Middle of the Night Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Zolpidem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Zaleplon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zaleplon</intervention_name>
    <description>10 mg</description>
    <arm_group_label>Zaleplon</arm_group_label>
    <other_name>Sonata</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>zolpidem extended release</intervention_name>
    <description>12.5 mg</description>
    <arm_group_label>Zolpidem</arm_group_label>
    <other_name>Ambien CR</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bedtime placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Bedtime Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>middle of the night placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Middle of the Night Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 50 years of age

          -  no sleep complaints or problems

          -  good sleep quality per questionnaire

          -  sufficient time in bed each night

        Exclusion Criteria:

          -  any clinically significant unstable medical condition

          -  recent psychiatric disorder

          -  prior diagnosis or symptoms of a sleep disorder

          -  recent history of substance abuse

          -  recent use of prescription hypnotic medication or over-the-counter sleep aid

          -  recent use of psychotropic medication

          -  history of adverse reaction to benzodiazepines

          -  body mass index &gt; 36

          -  currently pregnant or nursing

          -  currently working rotating or night shift

          -  consumption of &gt; 700 mg per day of xanthine-containing food or beverages

          -  consumption of &gt; 14 units of alcohol per week

          -  smoke &gt; 1 pack of cigarettes per day, use of chewing tobacco more than 3 times per
             day, or unable to refrain from smoking or chewing without distress or discomfort while
             in the sleep laboratory
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janine M Hall-Porter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Luke's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Luke's Hospital Sleep Medicine and Research Center</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Greenblatt DJ, Harmatz JS, von Moltke LL, Ehrenberg BL, Harrel L, Corbett K, Counihan M, Graf JA, Darwish M, Mertzanis P, Martin PT, Cevallos WH, Shader RI. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther. 1998 Nov;64(5):553-61.</citation>
    <PMID>9834048</PMID>
  </reference>
  <reference>
    <citation>Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. Fundam Clin Pharmacol. 2006 Aug;20(4):397-403.</citation>
    <PMID>16867025</PMID>
  </reference>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2010</study_first_submitted>
  <study_first_submitted_qc>July 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2010</study_first_posted>
  <last_update_submitted>August 25, 2014</last_update_submitted>
  <last_update_submitted_qc>August 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sleep</keyword>
  <keyword>memory</keyword>
  <keyword>hypnotics</keyword>
  <keyword>zaleplon</keyword>
  <keyword>zolpidem</keyword>
  <keyword>Sonata</keyword>
  <keyword>Ambien</keyword>
  <keyword>Hypnotics and Sedatives</keyword>
  <keyword>Polysomnography</keyword>
  <keyword>Monitoring, sleep</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zolpidem</mesh_term>
    <mesh_term>Hypnotics and Sedatives</mesh_term>
    <mesh_term>Zaleplon</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

